Skip to content

Arrhythmogenic Right Ventricular Dysplasia 3 C1865882

Published: July 22, 2026Updated: August 20, 2026

A genetic form of heart muscle disease where the right ventricle progressively replaces normal tissue with fat, causing electrical problems. Young people, especially athletes, are often affected. Management includes anti-arrhythmic drugs, procedures, and lifestyle modifications to lower sudden death risk.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
I78.0
ICD-11
BA00.0
Body system
cardiovascular
Severity
severe
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Sudden cardiac arrest

Chest discomfort or palpitations

(cardiovascular)

Significant symptoms that substantially affect daily functioning.

Frequency: Common at all stages

Palpitations

(cardiovascular)

Fatigue

(cardiovascular)

Dyspnea on exertion

(cardiovascular)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Antiarrhythmic Therapy

Pharmacological management using antiarrhythmic medications to control irregular heart rhythms and prevent ventricular tachycardia episodes. Regular cardiac monitoring is required to assess medication efficacy and potential side effects.

medication
2

Disease management and monitoring

Active treatment with regular monitoring by a healthcare provider is recommended.

medication
3

Implantable Cardioverter-Defibrillator (ICD)

Surgical placement of an ICD device to continuously monitor heart rhythm and deliver electrical shocks when life-threatening arrhythmias are detected. This serves as both treatment and prevention of sudden cardiac death.

surgical

Additional treatment options

Activity Restriction and Exercise Modification

Structured program limiting competitive athletics and high-intensity exercises that may trigger arrhythmias. Prescribed moderate physical activity tailored to individual capacity and disease progression.

lifestyle

Regular Cardiac Surveillance

Comprehensive monitoring program including periodic echocardiograms, Holter monitoring, and cardiac MRI to track disease progression and treatment effectiveness. Frequency adjusted based on disease severity.

monitoring

Catheter Ablation

Minimally invasive procedure using radiofrequency energy to destroy abnormal heart tissue causing arrhythmia triggers. Performed when medications are ineffective or not tolerated.

procedure

When to seek medical help

Recognize when you need immediate medical attention.

See a doctor within 24 hours

Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.

Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Arrhythmogenic Right Ventricular Dysplasia 3 C1865882?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Basso C, Corrado D, Thiene G, Marcus FI. Diagnosis and management of arrhythmogenic right ventricular cardiomyopathy. Heart Rhythm Society Guidelines. 2022.

guideline2022
2

McKenna WJ, Judge D, te Riele AS. Arrhythmogenic right ventricular cardiomyopathy: pathophysiology and genetics. Prog Cardiovasc Dis. 2020.

review2020
3

Leren IS, Saberniak J, Haland TF, Edvardsen T, Haugaa KH. Impact of genetic testing on risk stratification in arrhythmogenic right ventricular cardiomyopathy: a systematic review and meta-analysis. Europace. 2021.

meta_analysis2021
4

Gandjbakhch E, Redheuil A, Pousset F, Charron P. Cardiac magnetic resonance in ARVC: diagnostic accuracy and clinical outcomes. JACC Cardiovasc Imaging. 2019.

clinical_trial2019

Medication Comparisons

Compare medications used to treat Arrhythmogenic Right Ventricular Dysplasia 3 C1865882. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy